CN Stock MarketDetailed Quotes

002923 Zhuhai Rundu Pharmaceutical

Watchlist
  • 10.74
  • -0.15-1.38%
Market Closed Dec 13 15:00 CST
3.60BMarket Cap93.39P/E (TTM)

Zhuhai Rundu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Preparation356.96M59.78%
Raw material medicine233.6M39.12%
Pharmaceutical intermediates4.39M0.73%
Other business2.22M0.37%
Other----
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Chemical preparation manufacture356.96M59.78%
Raw material medicine manufacture237.98M39.85%
Other business2.22M0.37%
Other----
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region173.52M29.06%
South China region116.32M19.48%
Central China95.31M15.96%
Export sales75.47M12.64%
Southwest region74.21M12.43%
North China region30.07M5.04%
Northwest region21.85M3.66%
Northeast region8.2M1.37%
Other business2.22M0.37%
Other----
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Artemisinin
Artemisinin
Intraday-1.86%